• Profile
Close

Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: Results from FORTUNE-1, a prospective, multicentre randomised study

Annals of Rheumatic Diseases Nov 10, 2017

Yamanaka H, et al. - This study entailed the comparison between 3 preventive strategies for reducing gout flares during the initial introduction of urate-lowering therapy in patients with gout: stepwise dose increase of febuxostat, fixed-dose febuxostat + colchicine, and fixed-dose febuxostat. Findings demonstrated a greater efficacy of stepwise dose increase of febuxostat and low-dose colchicine prophylaxis in attenuating gout flares in comparison with fixed-dose febuxostat alone. It was observed that stepwise dose increase of febuxostat may be an effective alternative to low-dose colchicine prophylaxis during the introduction of urate-lowering therapy.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay